Edwin H. Kolodny
Affiliations: | Neurology | New York University, New York, NY, United States |
Google:
"Edwin Kolodny"Bio:
MD
NEW YORK NUNIVERSITY MEDICAL CENTER
NEUROLOGY DEPT
550 1ST AVE
NEW YORK, NY 100166402
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mistry PK, Batista JL, Andersson HC, et al. (2017) Transformation in Pre-treatment Manifestations of Gaucher Disease Type 1 during Two Decades of Alglucerase/Imiglucerase Enzyme Replacement Therapy in the International Collaborative Gaucher Group (ICGG) Registry. American Journal of Hematology |
| El-Beshlawy A, Tylki-Szymanska A, Vellodi A, et al. (2016) Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism |
| Desnick RJ, Barton NW, Furbish S, et al. (2016) Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues. Molecular Genetics and Metabolism |
| Tatlisumak T, Putaala J, Innilä M, et al. (2016) Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population. Journal of Neurology. 263: 257-262 |
| Kolodny E, Fellgiebel A, Hilz MJ, et al. (2015) Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke; a Journal of Cerebral Circulation. 46: 302-13 |
| Wessels ME, Holmes JP, Jeffrey M, et al. (2014) GM2 gangliosidosis in British Jacob sheep. Journal of Comparative Pathology. 150: 253-7 |
| Böttcher T, Rolfs A, Tanislav C, et al. (2013) Fabry disease - underestimated in the differential diagnosis of multiple sclerosis? Plos One. 8: e71894 |
| Pierson TM, Torres PA, Zeng BJ, et al. (2013) Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase. Molecular Genetics and Metabolism. 108: 65-9 |
| Leone P, Shera D, McPhee SW, et al. (2012) Long-term follow-up after gene therapy for canavan disease. Science Translational Medicine. 4: 165ra163 |
| Flint D, Li R, Webster LS, et al. (2012) Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Human Mutation. 33: 1141-8 |